Aura Biosciences gets FDA fast track status for belzupacap sarotalocan

Aura Biosciences has secured fast track designation for belzupacap sarotalocan (AU-011) from the US Food and Drug Administration (FDA) for the treatment of non-muscle invasive ... Read More